Neurotrophic Keratitis
Neurotrophic Keratitis is a rare eye condition characterized by reduced sensitivity in the cornea, which can lead to corneal damage, ulcers, and vision problems.
Neurotrophic Keratopathy: RGN-259 Eye Drops
We are studying a new eye drop solution for people with Neurotrophic Keratopathy. The trial will compare its effects to a placebo to see if it improves eye health.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Are you male or female and not currently pregnant or breastfeeding?
- Do you have a persistent eye condition that has not improved after one week of treatment?
- Have you had any major eye surgery in the last 3 months?
- Are you currently taking any medications that affect your eye health, like certain antidepressants or antihistamines?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Timbetasin acetate
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Azienda Socio Sanitaria Territoriale Santi Paolo E Carlo
Opthalmology
Assago, Italy
Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia
Ophthalology
Brescia, Italy
Azienda Ospedaliero Universitaria Careggi
Ophthalmology
Florence, Italy
Sponsor: Regentree LLC
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.